Difference in Rill Costs With INA-CBGs Rates and Treatment Rationality of Inpatient Asthma Children
Asthma in children may affect children's efficiency at school because frequent attacks occur which disrupt children's activities, so that asthma in children is a serious problem that requires appropriate treatment. The aim was to know the difference in real costs and INA-CBGs rates and to...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Mulawarman University
2024-12-01
|
Series: | Journal of Tropical Pharmacy and Chemistry |
Subjects: | |
Online Access: | https://jtpc.jurnalfamul.com/index.php/jtpc/article/view/619 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832584112042409984 |
---|---|
author | Amelia Lorensia Marthy Meliana Ariyanti Jalmav Adilah Fatin Amir Fida Shafi Anizzalati |
author_facet | Amelia Lorensia Marthy Meliana Ariyanti Jalmav Adilah Fatin Amir Fida Shafi Anizzalati |
author_sort | Amelia Lorensia |
collection | DOAJ |
description |
Asthma in children may affect children's efficiency at school because frequent attacks occur which disrupt children's activities, so that asthma in children is a serious problem that requires appropriate treatment. The aim was to know the difference in real costs and INA-CBGs rates and to analyze Drug-Related Problems (DRP) based on the severity of asthma and the real costs for childhood asthma at Anwar Medika Sidoarjo Hospital. The design of this study was retrospective using patient medical record data collection, for January 2020-December 2022. Data collection containing real cost data and BPJS claim cost data. Analysis of DRP based on PCNE (Pharmaceutical Care Network Europe) includes problems and causes. There were 77 subjects. the real costs for the severity of mild asthma class I, class III, and moderate asthma class II were high when compared with the INA-CBGS rates, while the severity level of severe asthma class III it was found that the real costs were lower than the INA-CBGS rates. There is no difference between total real costs and INA-CBGS rates for asthma cases in BPJS participating children. The average real cost is Rp. 2,557,453 and the average INA-CBGs tariff is Rp. 2,792,873. There was no significant difference between real costs and INA-CBGS rates (P=0.162). All respondents experienced DRP (100%) and the highest incidence of DRP was M3.1 and P1.2 in 44 people (57.14%) with 180 cases (60.82%). In 77 patients with a total number of cases of 296, the real costs were mostly incurred in class III mild asthma patients (58 people), namely DRP type M3.1 with P1.2 with an average cost of Rp. 2,640,221.
|
format | Article |
id | doaj-art-275b5e94838049d5b18ca2795056472b |
institution | Kabale University |
issn | 2087-7099 2407-6090 |
language | English |
publishDate | 2024-12-01 |
publisher | Mulawarman University |
record_format | Article |
series | Journal of Tropical Pharmacy and Chemistry |
spelling | doaj-art-275b5e94838049d5b18ca2795056472b2025-01-27T16:19:26ZengMulawarman UniversityJournal of Tropical Pharmacy and Chemistry2087-70992407-60902024-12-018210.25026/jtpc.v8i2.619Difference in Rill Costs With INA-CBGs Rates and Treatment Rationality of Inpatient Asthma ChildrenAmelia Lorensia0Marthy Meliana Ariyanti Jalmav1Adilah Fatin Amir2Fida Shafi Anizzalati3Department of Clinical Pharmacy-Community, Faculty of Pharmacy, University of Surabaya, Jl. Raya Kalirungkut, 60293 IndonesiaFaculty of Pharmacy, Universitas Anwar Medika, Jl. Parengan, Semawut, Balongbendo, Kec. BalongBendo, Kabupaten Sidoarjo, Jawa Timur 61262 IndonesiaDepartment of Clinical Pharmacy-Community, Faculty of Pharmacy, University of Surabaya, Jl. Raya Kalirungkut, 60293 IndonesiaDepartment of Clinical Pharmacy-Community, Faculty of Pharmacy, University of Surabaya, Jl. Raya Kalirungkut, 60293 Indonesia Asthma in children may affect children's efficiency at school because frequent attacks occur which disrupt children's activities, so that asthma in children is a serious problem that requires appropriate treatment. The aim was to know the difference in real costs and INA-CBGs rates and to analyze Drug-Related Problems (DRP) based on the severity of asthma and the real costs for childhood asthma at Anwar Medika Sidoarjo Hospital. The design of this study was retrospective using patient medical record data collection, for January 2020-December 2022. Data collection containing real cost data and BPJS claim cost data. Analysis of DRP based on PCNE (Pharmaceutical Care Network Europe) includes problems and causes. There were 77 subjects. the real costs for the severity of mild asthma class I, class III, and moderate asthma class II were high when compared with the INA-CBGS rates, while the severity level of severe asthma class III it was found that the real costs were lower than the INA-CBGS rates. There is no difference between total real costs and INA-CBGS rates for asthma cases in BPJS participating children. The average real cost is Rp. 2,557,453 and the average INA-CBGs tariff is Rp. 2,792,873. There was no significant difference between real costs and INA-CBGS rates (P=0.162). All respondents experienced DRP (100%) and the highest incidence of DRP was M3.1 and P1.2 in 44 people (57.14%) with 180 cases (60.82%). In 77 patients with a total number of cases of 296, the real costs were mostly incurred in class III mild asthma patients (58 people), namely DRP type M3.1 with P1.2 with an average cost of Rp. 2,640,221. https://jtpc.jurnalfamul.com/index.php/jtpc/article/view/619asthmareal costsINA-CBGsdrug-related problems |
spellingShingle | Amelia Lorensia Marthy Meliana Ariyanti Jalmav Adilah Fatin Amir Fida Shafi Anizzalati Difference in Rill Costs With INA-CBGs Rates and Treatment Rationality of Inpatient Asthma Children Journal of Tropical Pharmacy and Chemistry asthma real costs INA-CBGs drug-related problems |
title | Difference in Rill Costs With INA-CBGs Rates and Treatment Rationality of Inpatient Asthma Children |
title_full | Difference in Rill Costs With INA-CBGs Rates and Treatment Rationality of Inpatient Asthma Children |
title_fullStr | Difference in Rill Costs With INA-CBGs Rates and Treatment Rationality of Inpatient Asthma Children |
title_full_unstemmed | Difference in Rill Costs With INA-CBGs Rates and Treatment Rationality of Inpatient Asthma Children |
title_short | Difference in Rill Costs With INA-CBGs Rates and Treatment Rationality of Inpatient Asthma Children |
title_sort | difference in rill costs with ina cbgs rates and treatment rationality of inpatient asthma children |
topic | asthma real costs INA-CBGs drug-related problems |
url | https://jtpc.jurnalfamul.com/index.php/jtpc/article/view/619 |
work_keys_str_mv | AT amelialorensia differenceinrillcostswithinacbgsratesandtreatmentrationalityofinpatientasthmachildren AT marthymelianaariyantijalmav differenceinrillcostswithinacbgsratesandtreatmentrationalityofinpatientasthmachildren AT adilahfatinamir differenceinrillcostswithinacbgsratesandtreatmentrationalityofinpatientasthmachildren AT fidashafianizzalati differenceinrillcostswithinacbgsratesandtreatmentrationalityofinpatientasthmachildren |